Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA13 - Therapeutics and Radiation for Small Cell Lung Cancer
- 10:30 - 12:00
- 9/26/2018
- Location: Room 203 BD
- Type: Oral Abstract Session
- Track: Small Cell Lung Cancer/NET
-
+
OA13.01 - The Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial
10:30 - 10:40 | Presenter: Corinne Faivre-Finn | Author(s): Prakash Manoharan, Ahmed Salem, Hitesh Mistry, Michael Gornall, Susan V Harden, Peter Julyan, Imogen Locke, Jonathan McAleese, Rhona McMenemin, Nazia Mohammed, Michael Snee, Thomas Westwood, Sarah Woods
- Abstract
Loading... -
+
OA13.02 - Two Novel Immunotherapy Agents Targeting DLL3 in SCLC: Trials in Progress of AMG 757 and AMG 119
10:40 - 10:50 | Presenter: Taofeek Owonikoko | Author(s): Marie-Anne Damiette Smit, Hossein Borghaei, Ravi Salgia, Michael Boyer, Erik R. Rasmussen, Lauren Byers
- Abstract
Loading... -
+
OA13.03 - Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial
10:50 - 11:00 | Presenter: Ying Cheng | Author(s): Qiming Wang, Kai Li, Jianhua Shi, Lin Wu, Baohui Han, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaoling Li
- Abstract
Loading... -
+
OA13.04 - Discussant - OA 13.01, OA 13.02, OA 13.03
11:00 - 11:15 | Presenter: Normand Blais
- Abstract
No abstract available for this presentation
-
+
OA13.05 - Prophylactic Cranial Irradiation (PCI) for Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 CONVERT Trial
11:15 - 11:25 | Presenter: Cecile Le Pechoux | Author(s): Antonin Levy, Hitesh Mistry, Isabelle Martel-Lafay, Andrea Bezjak, Delphine Lerouge, Laetitia Padovani, Paul Taylor, Corinne Faivre-Finn
- Abstract
Loading... -
+
OA13.06 - Final Report of a Prospective Randomized Study on Thoracic Radiotherapy Target Volumes in Limited-stage Small Cell Lung Cancer with Radiation Dosimetric and Pathologic Analyses
11:25 - 11:35 | Presenter: Xiao Hu | Author(s): Yong Bao, Yu Jin Xu, Hui Neng Zhu, Jin Shi Liu, Li Zhang, Xinmin Yu, Yun Fan, Yi Ping Zhang, Wen Yong Sun, Weimin Mao, Ming Chen
- Abstract
Loading... -
+
OA13.07 - Survival Outcomes After Whole Brain Radiotherapy for Brain Metastases in Elderly Patients with Newly Diagnosed Metastatic Small Cell Carcinoma.
11:35 - 11:45 | Presenter: Paul Renz | Author(s): Shaakir Hasan, Andrew Turrisi Iii, Athanasios Colonias, Rodney Wegner
- Abstract
Loading... -
+
OA13.08 - Discussant - OA 13.05, OA 13.06, OA 13.07
11:45 - 12:00 | Presenter: Inga Grills
- Abstract
No abstract available for this presentation
-
+
PC09 - Approaches to Management of Advanced NSCLC
- 10:30 - 12:00
- 9/26/2018
- Location: Room 107
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC09.01 - Debate 1: Early vs Delayed Treatment of Asymptomatic Brain Metastases in Wild-Type NSCLC - Early
10:30 - 10:45 | Presenter: Qing Zhou
- Abstract
No abstract available for this presentation
-
+
PC09.02 - Debate 1: Early vs Delayed Treatment of Asymptomatic Brain Metastases in Wild-Type NSCLC - Delayed
10:45 - 11:00 | Presenter: Walter John Curran, Jr.
- Abstract
No abstract available for this presentation
-
+
PC09.03 - Discussion
11:00 - 11:15
- Abstract
No abstract available for this presentation
-
+
PC09.04 - Debate 2: Large Cell Neuroendocrine Carcinoma Should Be Treated like NSCLC or SCLC? - NSCLC
11:15 - 11:30 | Presenter: Noemi Reguart
- Abstract
No abstract available for this presentation
-
+
PC09.05 - Debate 2: Large Cell Neuroendocrine Carcinoma Should Be Treated like NSCLC or SCLC? - SCLC
11:30 - 11:45 | Presenter: Scott A. Laurie
- Abstract
No abstract available for this presentation
-
+
PC09.06 - Discussion
11:45 - 12:00
- Abstract
No abstract available for this presentation
-
+
P3.01 - Advanced NSCLC (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.01-02 - Patients with a Smaller Primary Tumor and Fewer Metastases Could be Cured Even in Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Takuya Aoki | Author(s): Naoki Okada, Keito Enokida, Shigeaki Hattori, Tomoe Takeuchi, Fuminari Takahashi, Genki Takahashi, Kazuki Harada, Jun Tanaka, Masako Sato, Yukihiro Horio, Hiroto Takiguchi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Takahisa Takihara, Kyoko Niimi, Naoki Hayama, Tsuyoshi Oguma, Tetsuya Urano, Koichiro Asano
- Abstract
Loading... -
+
P3.01-03 - The Cost Benefit from Second Line Immunotherapy in Metastatic NSCLC: ASCO Value Framework Prospective
12:00 - 13:30 | Presenter: Ahmed Ashour Badawy | Author(s): Gehan Khedr, Waleed Arafat
- Abstract
Loading... -
+
P3.01-04 - Immune Checkpoint Inhibitors (ICIs) in NSCLC: Immune Related Adverse Events (irAEs) and Outcomes. A Canadian Single Institution Experience.
12:00 - 13:30 | Presenter: Kiran Virik | Author(s): Bassam Basulaiman, Andrew G Robinson, Wilma Hopman, Kiran Virik
- Abstract
Loading... -
+
P3.01-05 - Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy
12:00 - 13:30 | Presenter: Marta Batus | Author(s): Parva Kiran Bhatt, Philip Bonomi, Sanjib Basu
- Abstract
Loading... -
+
P3.01-06 - Concomitant Plasma-Genotyped T790M Positivity and Small Cell Carcinoma Transformation in EGFR-Mutated NSCLC
12:00 - 13:30 | Presenter: Sourin Bhuniya | Author(s): Prasanta Raghab Mohapatra, Pritinanda Mishra, Susama Patra, Manoj Kumar Panigrahi, Gourahari Pradhan, Satyajeet Sahoo, Swagatika Samal
- Abstract
Loading... -
+
P3.01-07 - Outcome and Prognostic Factors in ALK+ve Metastatic Adenocarcinoma of Lung: Single Center Experience From Eastern India
12:00 - 13:30 | Presenter: Bivas Biswas | Author(s): Deepak Dabkara, Sandip Ganguly, Raj kumar Shrimali, Joydeep Ghosh, Prasad E, Divya Midha, Geetashree Mukherjee, Mayur Parihar, Deeapk Kumar Mishra, Neeraj Arora
- Abstract
Loading... -
+
P3.01-08 - Gender Differences in Lung Cancer Survival
12:00 - 13:30 | Presenter: Marko Jakopovic | Author(s): Lela Bitar, Fran Seiwerth, Dražena Srdić, Ana Bačelić-Gabelica, Sanja Pleština, Miroslav Samaržija
- Abstract
Loading... -
+
P3.01-09 - Impact of Urban or Rural Residence on Overall Survival for Patients with Metastatic Non-Squamous NSCLC
12:00 - 13:30 | Presenter: Jacqueline Theresa Brown | Author(s): Lisa Xiang Li, Margaret Moore, Andrew Reese Moore, Rajesh Piyush Desai, Ryan Gentzler, Rajesh Balkrishnan, Richard Hall
- Abstract
Loading... -
+
P3.01-10 - Dyspnea as a Prognostic Factor in Hispanic Patients with Non-Small Cell Lung Cancer Cohort
12:00 - 13:30 | Presenter: Saul Campos-Gomez | Author(s): Karen A Campos-Gomez, Juan J Valdés-Andrade
- Abstract
Loading... -
+
P3.01-100 - Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib
12:00 - 13:30 | Presenter: Kyaw Zin Thein | Author(s): Sriman Swarup, Somedeb Ball, Miguel Quirch, Yuttiwat Vorakunthada, Saad Khan, Fred Hardwicke, Sanjay Awasthi, Lukman Tijani
- Abstract
Loading... -
+
P3.01-101 - A Retrospective Study of Lung Cancer that has Progressed to Brain Metastasis Alone
12:00 - 13:30 | Presenter: Kenjiro Tsuruoka | Author(s): Hiroyuki Tsuji, Keiji Miyoshi, Ninso Matsunaga, Takahiko Nakamura, Yosuke Tamura, Masafumi Imanishi, Soichiro Ikeda, Yasuhito Fujisaka, Isao Goto
- Abstract
Loading... -
+
P3.01-102 - Potential Predictors of Unexpected Readmission After Lung Resection
12:00 - 13:30 | Presenter: Shinsuke Uchida | Author(s): Yukihiro Yoshida, Keisuke Asakura, Kazuo Nakagawa, Shun-ichi Watanabe
- Abstract
Loading... -
+
P3.01-103 - Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Multicenter Retrospective Study
12:00 - 13:30 | Presenter: Shouzheng Wang | Author(s): Puyuan Xing, Di Ma, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P3.01-104 - EGFR-RAD51 Fusion Variant in Lung Adenocarcinoma and Response to Erlotinib: A Case Report
12:00 - 13:30 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Wu Zhuang, Zhengbo Song, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P3.01-105 - Retrospective Analysis of Efficacy and Safety in Chinese Elderly Patients Treated with Nab-Paclitaxel
12:00 - 13:30 | Presenter: Shuhang Wang | Author(s): Qiu Ping, Jun Zhao
- Abstract
Loading... -
+
P3.01-106 - Real-World Data to Evaluate the Clinical Benefit of NGS for Directing Lung Adenocarcinoma Treatment
12:00 - 13:30 | Presenter: Zhaoxia Wang | Author(s): Binbin Lu, Guojian Liu, Tianwei Xu, Mingming Yuan, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P3.01-107 - Correlation Study of Bone Metastasis and Cholesterol Level in Patients with Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Yan Wang
- Abstract
Loading... -
+
P3.01-108 - Oncologist Treatment Considerations and Selection in EGFR M+ NSCLC
12:00 - 13:30 | Presenter: Vera Hirsh | Author(s): Thomas Wehler, Bernd Tischer, Steffen Reisgys
- Abstract
Loading... -
+
P3.01-109 - Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Loretta A Williams | Author(s): Seydeh Dibaj, Sheenu Chandwani, Viralkumar Bharatbhai Vaghani, Qiuling Shi, Meita Hirschmann, Lara Lacerda Landry, Emily Roarty, Jianjun Zhang, Waree Rinsurnogkawong, Jeff Lewis, Thomas Burke, Charles Cleeland, Jack Lee, Jack A Jack A. Roth, Stephen Swisher, John V Heymach, George R. Simon
- Abstract
Loading... -
+
P3.01-11 - Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Luisa Ricaurte, Alejandro Ruiz-Patiño, Claudio Martin, Hernan Carranza, Carlos Vargas, Jorge Otero, Luis Corrales
- Abstract
Loading... -
+
P3.01-110 - Defining Aggressive Disease in Patients With Advanced NSCLC Receiving Second-Line Treatment: A Systematic Review
12:00 - 13:30 | Presenter: Cliff Molife | Author(s): Katherine B Winfree, Claire Ainsworth, Annete Njue, Matthew Lyall, Min-Hua Jen, Marisa Bittoni, Anne Heyes, David P Carbone
- Abstract
Loading... -
+
P3.01-111 - Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients with NSCLC Harboring Sensitive EGFR Mutations
12:00 - 13:30 | Presenter: Yutaka Yamada | Author(s): Hisao Imai, Tomohide Sugiyama, Hiroyuki Minemura, Kyoichi Kaira, Kenya Kanazawa, Takashi Kasai, Takayuki Kaburagi, Koichi Minato
- Abstract
Loading... -
+
P3.01-112 - The Prognosis of Lung Cancer Patients with Unexpected Malignant Pleural Effusion and Without Pleural Dissemination Detected at Thoracotomy
12:00 - 13:30 | Presenter: Takashi Yamamichi | Author(s): Masahiko Harada, Ayaka Asakawa, Masayuki Okui, Hirotoshi Horio
- Abstract
Loading... -
+
P3.01-113 - A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)
12:00 - 13:30 | Presenter: Qing Zhou | Author(s): Ping Yu, Yong Song, Xin Zhang, Gongyan Chen, Yi Ping Zhang, Jianhua Chen, Zhuang Yu, Yi Hu, Xia Song, Diansheng Zhong, Guosheng Feng, Lulu Yang, Lujing Zhan, Luan Di Yao, Yun Chen, Yue Gao, Yi-Long Wu
- Abstract
Loading... -
+
P3.01-114 - Dissociation of Heart and Great Vessels for Long Tracheal Tumors and Lung Cancer Invaded Trachea: The Chinese Experience.
12:00 - 13:30 | Presenter: Qinghua Zhou
- Abstract
Loading... -
+
P3.01-115 - Liposomal Paclitaxel Versus Gemcitabine: Which is Better?
12:00 - 13:30 | Presenter: Xiangdong Zhou | Author(s): Liu Pan, Liang Lan
- Abstract
Loading... -
+
P3.01-116 - Randomized Clinical Trial on Three Different Platinum Based Chemotherapy in Advanced NSCLC in Bangladeshi Population
12:00 - 13:30 | Presenter: Ferdous ARA Begum | Author(s): Nazrina Khatun, Parveen Shahida Akhtar, A S M Fazlul Karim Chowdhury, Md. Arifur Rahman, Qamruzzaman Chowdhury
- Abstract
Loading... -
+
P3.01-12 - EGFR Mutation and Targeted Therapies: Difficulties and Disparities in Access to NSCLC Treatment in Brazil.
12:00 - 13:30 | Presenter: Gilberto Castro Jr | Author(s): Eduardo Cronemberger, Clarissa Baldotto, Felipe Marinho, Pedro De Marchi, Luiz H. Araujo, Fabio Andre Franke, Paulo Salles, Aknar Calabrich, Thais Almeida, Marcelo Graziano Custodio, Cleomines Araujo, Marcelo Horacio
- Abstract
Loading... -
+
P3.01-13 - Prognosis of Non-driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)
12:00 - 13:30 | Presenter: Anna Chalmers | Author(s): Ben Haaland, Shiven Patel, Kelly Moynahan, Laura Cannon, Wallace Akerley
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-15 - Efficacy of Paclitaxel Plus TS1 Against Non-Small Cell Lung Cancer Previously Treated
12:00 - 13:30 | Presenter: Yuh-Min Chen | Author(s): Yen-Han Tseng, Jen-Fu Shih, Heng-Sheng Chao
- Abstract
Loading... -
+
P3.01-16 - Low Dose Apatinib Combined with EGFR-TKI in Treating Advanced NSCLC After First-Generation EGFR-TKIs Treatment Failure
12:00 - 13:30 | Presenter: mingda Chen | Author(s): Junli Song, Weidong Liu
- Abstract
Loading... -
+
P3.01-17 - Long Survivors with Advanced Lung Cancer - Efficacy and Tolerability of Nivolumab
12:00 - 13:30 | Presenter: Ewa Chmielowska | Author(s): Anna Krause, Monika Olejniczak, Marcin Swiezynski, Jan Kopec
- Abstract
Loading... -
+
P3.01-18 - Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients with Lung Cancer
12:00 - 13:30 | Presenter: Jang Ho Cho | Author(s): Jiyeon Hyeon, Yoon-La Choi, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P3.01-19 - Sequencing of Ramucirumab+Docetaxel Post-Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Cliff Molife | Author(s): Jeffrey Melson Clarke, Victoria Jennifer Stefaniak, Marta Batus, Katherine B Winfree, Zhanglin L Cui, Yimei Han, Mahesh K Tawney, Philip Bonomi
- Abstract
Loading... -
+
P3.01-20 - Advanced NSCLC Treatment and Outcomes After Nivolumab
12:00 - 13:30 | Presenter: Girish Mallesara | Author(s): Elizabeth Anne Connolly, Ina Nordman
- Abstract
Loading... -
+
P3.01-21 - Metastatic Lung Carcinoma —An Institutional Experience from Eastern India
12:00 - 13:30 | Presenter: Saroj Kumar Das Majumdar | Author(s): Subhasis Mishra, Deepak Kumar Das, Sovan Sarang Dhar, Nabiza Begum, Saroj Kumar Das, Susama Patra, Sudipta Mohakud, Prasanta Raghab Mohapatra, Dillip Kumar Parida
- Abstract
Loading... -
+
P3.01-22 - An Exploratory Analysis of PD-L1 Expression and Smoking History in a Cohort of Advanced Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Marios P Decatris | Author(s): Philippe Taniere, Mark Hayes, Joy Thomas, Ketan Gaikwad, Maninder Kalkat, Kate Birchall, Jan Osbaldiston, Aled Phillips, Phil Ryan, Nick Reed, Ingrid Du Rand
- Abstract
Loading... -
+
P3.01-23 - Imaging Modalities for Surveillance and Follow-Up of Patient with Lung Cancer After Adjuvant Chemotherapy
12:00 - 13:30 | Presenter: Aya El Helali | Author(s): Laura Feeney, Catherine Joan Davidson, Kirsty Taylor, Michael John Devlin, Paula Scullin, Lynn Campbell
- Abstract
Loading... -
+
P3.01-24 - The Importance to Switch from EGFR-TKI to Cytotoxic Chemotherapy for EGFR Mutation-Positive Adenocarcinoma
12:00 - 13:30 | Presenter: Daisuke Eriguchi | Author(s): Tetsuya Okano, Yohei Kawaguchi, Junichi Maeda, Masaru Hagiwara, Masatoshi Kakihana, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
P3.01-25 - Feasibility of Moderate Hypofractionated Thoracic Irradiation for Non-Small Cell Lung Cancer Patients with Very Limited Lung Function
12:00 - 13:30 | Presenter: Maurice Dantes | Author(s): Farkhad Manapov, Olarn Roengvoraphoj, Julian Taugner, Lukas Käsmann, Cherylina Wijaya, Nina-Sophie Schmidt-Hegemann, Claus Belka, Chukwuka Eze
- Abstract
Loading... -
+
P3.01-26 - A Framework for Systematic Clinical Evaluation of Technical Innovations in Lung Cancer Patients Treated on the MR-Linac (MRL)
12:00 - 13:30 | Presenter: Corinne Faivre-Finn | Author(s): David Catharina Petrus Cobben, Hannah Bainbridge, Jose Belderbos, Patrick Cheung, Michael Dubec, Daniel Gomez, Elizabeth Gore, Elizabeth Knowles, Ferry Lalezari, Uwe Oelfke, Jan-Jakob Sonke, Rob H.N. Tijssen, Corine Van Es, Marcel Van Herk, Andreas Wetscherek, Fiona McDonald
- Abstract
Loading... -
+
P3.01-27 - Characterization and Sensitization of Non-Small Cell Lung Cancer Cell Line Variants Selected for Resistance to Osimertinib
12:00 - 13:30 | Presenter: Peter John Ferguson | Author(s): Mark David Vincent, James Koropatnick
- Abstract
Loading... -
+
P3.01-28 - The Clinical Impact of Comprehensive cfDNA Genomic Testing in Lung Cancer
12:00 - 13:30 | Presenter: Laila C Roisman | Author(s): Smadar Geva, Anna Belilovski Rozenblum, Tal Twito, Roxana Denisa Grinberg, Addie Dvir, Lior Soussan Gutman, Maya Ilouze, Elizabeth Dudnik, Alona Zer, Ofer Rotem, Richard B Lanman, Nir Peled
- Abstract
Loading... -
+
P3.01-29 - St.Iv Lung Adenocarcinoma Treated by First-Line EGFR–Tyrosine Kinase Inhibitors-Survival, EGFR Mutation, Histologic Subtype
12:00 - 13:30 | Presenter: Tomasz Gil | Author(s): Grzegorz Czyżewicz, Marta Skoczek, Piotr Wójcik, Piotr Hajder, Batrosz Kołodziejczyk, Wiktor Cieślak, Jarosław Kużdżał
- Abstract
Loading... -
+
P3.01-30 - Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan
12:00 - 13:30 | Presenter: Yasushi Goto | Author(s): Nobuyuki Yamamoto, Elizabeth T. Masters, Hironori Kikkawa, Jack Mardekian, Robin Wiltshire, Kanae Togo, Heyun Ma, Yuichiro Ohe
- Abstract
Loading... -
+
P3.01-31 - Prognostic Factors in Patients with Resected Pathological N2 Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Tatsuya Goto | Author(s): Masaya Nakamura, Yuki Shimizu, Seijiro Sato, Terumoto Koike, Masanori Tsuchida
- Abstract
Loading... -
+
P3.01-33 - EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis
12:00 - 13:30 | Presenter: Mahmut Gumus | Author(s): Akın Ozturk, Sinemis Celik, Hilmi Kodaz, Ibrahim Yildiz, Ayse Ocak, Ilhan Hacibekiroglu, Ibrahim Vedat Bayoglu, Ozlem Ercelep, Ahmet Siyar Ekinci, Serkan Menekse, Ozge Gumusay, Basak Oven, Mehmet Naci Aldemir, Caglayan Geredeli, Meltem Baykara, Mukremin Uysal, Alper Sevinc, Asude Aksoy, Arife Ulas, Mevlude Inanc, Ozgur Tanriverdi, Nilufer Avci, Nedim Turan
- Abstract
Loading... -
+
P3.01-34 - Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy
12:00 - 13:30 | Presenter: Tetsunari Hase | Author(s): Masayuki Miyazaki, Kazuya Ichikawa, Naoyuki Yogo, Naoya Ozawa, Masahiko Ando, Masahiro Morise, Mitsuo Sato, Masashi Kondo, Kiyofumi Yamada, Yoshinori Hasegawa
- Abstract
Loading... -
+
P3.01-35 - Outcomes in Advanced Non-Small Cell Lung Cancer After Discontinuation of PD-1 Checkpoint Inhibitor Due to Toxicity. A Retrospective Study
12:00 - 13:30 | Presenter: Jonathon Hill | Author(s): Adnan Nagrial, Rina Hui
- Abstract
Loading... -
+
P3.01-36 - Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Marta Honorio | Author(s): Nuno Guerra Pereira, Andreia Tereso, Maria Amélia Almeida
- Abstract
Loading... -
+
P3.01-37 - Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients with Wild-Type EGFR: TORG 1320
12:00 - 13:30 | Presenter: Shinobu Hosokawa | Author(s): Sakiko Otani, Jiichiro Sasaki, Tomoya Fukui, Yoshiro Nakahara, Akihiro Bessho, Nobuaki Fukamatsu, Yukiko Nakamura, Takashi Kasai, Tomohide Sugiyama, Takaaki Tokitho, Nobuhiko Seki, Akinobu Hamada, Noriyuki Masuda, Hiroaki Okamoto
- Abstract
Loading... -
+
P3.01-38 - Therapeutic Effects of FMNP-MSC for Hyperthermia on Lung Cancer A549 in Nude Mice
12:00 - 13:30 | Presenter: Runlei Hu
- Abstract
Loading... -
+
P3.01-39 - Analysis of Acquired EGFR T790M Mutation in Patients with Non-Small Cell Lung Cancer Who Received Icotinib Progress
12:00 - 13:30 | Presenter: Chunwei Xu | Author(s): Rongfang Huang, Wenxian Wang, Jianying Li, Cheng He, Youcai Zhu, Wu Zhuang, Zhangzhou Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P3.01-40 - Treatment of Super Elderly Patients for Non-Small Cell Lung Cancer in Japan
12:00 - 13:30 | Presenter: Tatsuya Ibe | Author(s): Hiroaki Kodama, Yoichiro Hamamoto
- Abstract
Loading... -
+
P3.01-41 - Anatomical and Clinical Basis of #11 LN by Systematic Bilateral Mediastinal Nodal Dissection for Left Lung Cancer through Median Sternotomy
12:00 - 13:30 | Presenter: Shingo Ikeda | Author(s): Toshiya Yokota, Kurumi Fukui, Tatsuhiro Hoshino
- Abstract
Loading... -
+
P3.01-42 - Phase II Trial Allowed Surgery After Induction Chemotherapy of CBDCA+PTX, Bevacizumab in Patients with Stages IIIA-IV Nonsquamous NSCLC
12:00 - 13:30 | Presenter: Kazuhiro Imai | Author(s): Taku Nakagawa, Ikuo Matsuzaki, Kimito Orino, Hajime Saito, Kazuhiro Sato, Masaaki Sano, Yusuke Sato, Satoru Motoyama, Hiroyuki Shibata, Yoshihiro Minamiya
- Abstract
Loading... -
+
P3.01-43 - Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hisao Imai | Author(s): Hiroyuki Minemura, Hiroshi Moriya, Tomohide Sugiyama, Yutaka Yamada, Mitsunori Higuchi, Kyoichi Kaira, Yuki Ozaki, Kenya Kanazawa, Hiroshi Yokouchi, Takashi Kasai, Takayuki Kaburagi, Hiroyuki Suzuki, Koichi Minato, Yoko Shibata
- Abstract
Loading... -
+
P3.01-44 - CYFRA 21-1 As a Predictor to Response to Chemotherapy and Overall Survival in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Kashif Iqbal
- Abstract
Loading... -
+
P3.01-45 - Multifactorial Gene Alterations in EGFR Bypass Pathway are Induced by Afatinib in T790M-Mutant NSCLC Resistant to Osmertinib
12:00 - 13:30 | Presenter: Hidenobu Ishii | Author(s): Koichi Azuma, Kazuko Sakai, Yoshiko Naito, Norikazu Matsuo, Takaaki Tokito, Kazuhiko Yamada, Tomoaki Hoshino, Kazuto Nishio
- Abstract
Loading... -
+
P3.01-46 - Prognostic Utility of Advanced Lung Cancer Inflammation Index (ALI) in Thoracic Malignancies: A Meta-Analysis
12:00 - 13:30 | Presenter: Syed Hasan Raza Jafri | Author(s): Hazem Elosta
- Abstract
Loading... -
+
P3.01-47 - Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
12:00 - 13:30 | Presenter: Xue Ji | Author(s): Xingsheng Hu, Yixiang Zhu, Yutao Liu, Lin Lin, Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li
- Abstract
Loading... -
+
P3.01-48 - The Efficiency of Low-Dose Apatinib in Treatment of Advanced Lung Squamous Cell Carcinoma
12:00 - 13:30 | Presenter: Yu-Ming jia | Author(s): Ting Li, Shan-Bin Wang, Kai-Jian Lei, Bang-Xian Tan, Li-Hua Qiu, Mao-Qiong Jiang, Jian Jiang, Lei-Ya Du, Ye Qiu, Xia Zhang, Ming-Zong Hu, Wen-Jing Ye, Yu-Lan Jiang
- Abstract
Loading... -
+
P3.01-49 - Effciency of Low-Dosage Apatinib Monotherapy in Treatment of Advanced Lung Squamous Cell Carcinoma
12:00 - 13:30 | Presenter: Hua Jiang | Author(s): Qian Geng, Mengjie Wang, Yingzhi Lu, Wenyu Zhu, Zhiqiang Sun
- Abstract
Loading... -
+
P3.01-50 - Identification of EGFR Mutational Profile in Lung Cancer Moroccan Cohort
12:00 - 13:30 | Presenter: Houda Kaanane | Author(s): Hicham El Atar, Latifa Badre, Amal Louahabi, Hind Berradi, Meriem Khyatti, Sellama Nadifi
- Abstract
Loading... -
+
P3.01-51 - Outcomes with Systemic Chemotherapy in Advanced NSCLC Patients with Performance Status 2 and Above and without Driver Mutation
12:00 - 13:30 | Presenter: Harish Kancharla | Author(s): Prabhat S. Malik, Sachin Khurana, Naresh Gundu, Ajay Yadav, Deepali Jain, Sushmita Pathy, Sunil Kumar
- Abstract
Loading... -
+
P3.01-52 - The Role of Serum Carcinoembryonic Antigen to Predict the Response of Treatment in Non‑Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Muhammet Ali Kaplan | Author(s): Nadiye Akdeniz, Mehmet Kucukoner, Zuhat Urakci, Ogur Karhan, Abdurrahman İsikdogan
- Abstract
Loading... -
+
P3.01-53 - Comparison of the Treatment Efficacy of Osimertinib in Young and Elderly Patients with T790M-Positive NSCLC
12:00 - 13:30 | Presenter: Yasuhiro Kato | Author(s): Yukio Hosomi
- Abstract
Loading... -
+
P3.01-54 - A Historical Comparison of Patients with Advanced NSCLC Harboring Uncommon EGFR Mutations Before and After the Approval of Afatinib in Japan
12:00 - 13:30 | Presenter: Takahisa Kawamura | Author(s): Haruyasu Murakami, Haruki Kobayashi, Kazuhisa Nakashima, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Masahiro Endo, Toshiaki Takahashi
- Abstract
Loading... -
+
P3.01-55 - SF2: A PCYT-2 Inhibitor Prototype is Capable of Inducing Citotoxicity in NSCLC
12:00 - 13:30 | Presenter: Bárbara Kawamura | Author(s): Sarah Fernandes Teixeira, Lisley Inata Mambelli, Salomão Doria Jorge, Marcio Henrique Zaim, Kerly Fernanda Mesquita Pasqualoto, Debora Levy, Jose Alexandre Marzagão Barbuto, Adilson Kleber Ferreira
- Abstract
Loading... -
+
P3.01-56 - Hyperprogression and Pseudoprogression in Patients with Non-Small Cell Lung Cancer on Checkpoint Blocking Immunotherapy
12:00 - 13:30 | Presenter: Seoree Kim | Author(s): Joori Kim, Sook-Hee Hong, Jin-Hyoung Kang, Sang Hoon Chun
- Abstract
Loading... -
+
P3.01-57 - Real-World (RW) Predictors of Immuno-Oncology (IO) vs Chemotherapy (C) Use in Advanced Non-Small Cell Lung Cancer (aNSCLC)
12:00 - 13:30 | Presenter: Bruce Feinberg | Author(s): Janna Radtchenko, Beata Korytowsky, Esmond Nwokeji, Ken Tuell
- Abstract
Loading... -
+
P3.01-58 - Relative Abundance Of EGFR Mutations in Plasma Predicts Tumor Response to EGFR-TKI in Advanced Lung Adenocacarcinoma
12:00 - 13:30 | Presenter: Yuping Li | Author(s): Hanyan Xu, Sansan Su, Junru Ye, Chengshui Chen
- Abstract
Loading... -
+
P3.01-59 - Comparison of Lobectomy, Segmentectomy and Wedge Resection for Early Stage NSCLC: A Direct and Network Meta-Analysis
12:00 - 13:30 | Presenter: Wang Liang
- Abstract
Loading... -
+
P3.01-60 - A Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient with Acquired MET Amplification
12:00 - 13:30 | Presenter: Ying Liang | Author(s): Qinchang Chen, Yongbin Lin, Hui Liu, Bo Qiu
- Abstract
Loading... -
+
P3.01-61 - EGFR and KRAS Mutational Status and Significance in Greek Patients with Advanced Non Small Cell Lung Cancer
12:00 - 13:30 | Presenter: George Fountzilas | Author(s): Helena Linardou, Vassiliki Kotoula, George Kouvatseas, Vasilios Karavasilis, Giannis Mountzios, Epaminontas Samantas, Anna Kalogera-Fountzila, Despina Televantou, Kyriaki Papadopoulou, Xanthipi Mavropoulou, Emily Daskalaki, Thomas Zaramboukas, Ioannis Efstratiou, Sofia Lambaki, Grigorios Rallis, Eleni Res, Konstantinos Syrigos, Paris Kosmidis, Dimitrios Pectasides
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-64 - Preliminary Data of Diverse Therapies in Patients with Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement
12:00 - 13:30 | Presenter: Chang Lu | Author(s): Hai-Yan Tu, Hong-Hong Yan, Xu-Chao Zhang, Bin-Chao Wang, Zhen Wang, Anna Li, Jia-xin Lin, Yang-Si Li, E-E Ke, Jin Song, Si Chen, Yuqi Wang, Yanfang Guan, Xuefeng Xia, Xin Yi, Yi-Long Wu, Jin -Ji Yang
- Abstract
Loading... -
+
P3.01-65 - First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-Mutant Metastatic NSCLC Receiving TKIs
12:00 - 13:30 | Presenter: Jingbo Wang | Author(s): Xiaotong Lu, Chunyu Wang, Nan Bi, Zongmei Zhou, Yan Wang, Luhua Wang
- Abstract
Loading... -
+
P3.01-66 - Clinicopathological Characteristics and Mutation Status of Pulmonary Invasive Mucinous Adenocarcinoma
12:00 - 13:30 | Presenter: Fangliang Lu
- Abstract
Loading... -
+
P3.01-67 - Integrated Network Analysis to Understand the Potential Mechanisms of Hydroxychlrorquine in Non-Small Cell Lung Cancer Treatment
12:00 - 13:30 | Presenter: Jingyun Chen | Author(s): Xin Lyu, Lizhong Zeng, Jingyan Yuan, Xia Meng, Ruiying Sun, Boxuan Liu, Ying Bai, Xuan Liu, Zongfang Li, Shuanying Yang
- Abstract
Loading... -
+
P3.01-68 - Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients with Advanced NSCLC Harboring EGFR Mutations
12:00 - 13:30 | Presenter: Dongqing Lv | Author(s): Wei Wang, Jiapei Ding, Xiaomai Wu, Chao Zhou, Biyun Wang, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P3.01-69 - Stereotactic Ablative Radiotherapy Improves Progression-Free Survival & Local Control in Oligometastatic Lung Cancer Patients
12:00 - 13:30 | Presenter: Federico Maldonado
- Abstract
Loading... -
+
P3.01-70 - Meta-Analysis of Metformin in Combination with Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Kristen A. Marrone | Author(s): Anish Parikh, Daniel Becker, Julie R. Brahmer, David S Ettinger, Benjamin P Levy
- Abstract
Loading... -
+
P3.01-71 - Results of Extended Resection in T4 Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Takeshi Matsunaga | Author(s): Kenji Suzuki, Kazuya Takamochi, Shiaki Oh
- Abstract
Loading... -
+
P3.01-72 - Pulmonary Resection in a Prone Position for Lung Cancer Invading the Spine: Two Cases Report
12:00 - 13:30 | Presenter: Shunsaku Miyauchi | Author(s): Junichi Soh, Kota Araki, Akihiro Miura, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Kazuhiko Shien, Hiromasa Yamamoto, Seiichiro Sugimoto, Masaomi Yamane, Shinichi Toyooka
- Abstract
Loading... -
+
P3.01-73 - Talc Versus Minocycline and OK-432 Pleurodesis for Malignant Pleural Effusion.
12:00 - 13:30 | Presenter: EISUKE Mochizuki | Author(s): Yasutaka Mochizuka, Kyohei Oishi, Hyogo Naoi, Shun Matsuura, Shinichiro Mikura, Miyuki Nagaoka, Masaru Tsukui, Naoki Koshimizu
- Abstract
Loading... -
+
P3.01-74 - Clinical and Radiological Predictors of Efficacy to Nivolumab in NSCLC: A Multi-Institutional, Retrospective Cohort Study.
12:00 - 13:30 | Presenter: Rebecca Jane Moor | Author(s): Kate E Roberts, Rahul Ladwa, Kenneth Miles, Kenneth O’byrne
- Abstract
Loading... -
+
P3.01-75 - RELAY+, an Exploratory Study of Gefitinib with Ramucirumab in Untreated Patients with EGFR Mutation-Positive Metastatic NSCLC
12:00 - 13:30 | Presenter: Makoto Nishio | Author(s): Kazuto Nishio, Kazumi Suzukawa, Yukie Omori, Sotaro Enatsu, Carla Visseren-Grul, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P3.01-76 - Clinical Background and Response to Chemotherapy in NSCLC Patients with MET Exon14 Skipping Mutation or High MET Gene Copy Number
12:00 - 13:30 | Presenter: Kaname Nosaki | Author(s): Yasuhiro Umeyama, Ryo Toyozawa, Shinkichi Takamori, Naoki Haratake, Naoko Miura, Taro Oba, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose
- Abstract
Loading... -
+
P3.01-77 - Clinical Characteristics of Korean Lung Cancer Patients with Programmed Death-Ligand 1 Expression
12:00 - 13:30 | Presenter: In-Jae Oh | Author(s): Ha-Young Park, Cheol-Kyu Park, Young-Chul Kim, Sang-Yun Song, Seok Kim, Yoo Duk Choi
- Abstract
Loading... -
+
P3.01-78 - The Cytology Samples and Plasma Specimens were Feasible for the EGFR Molecular Testing.
12:00 - 13:30 | Presenter: Tatsuo Ohira | Author(s): Wakako Hamanaka, Yoshihisa Shimada, Sachio Maehara, Junichi Maeda, Masaru Hagiwara, Masatoshi Kakihana, Tetsuya Okano, Naohiro Kajiwara, Norihiko Ikeda
- Abstract
Loading... -
+
P3.01-79 - Intracerebral Efficacy of Immune Check-Point Inhibitors in NSCLC Patients with Brain Metastases
12:00 - 13:30 | Presenter: Fumiyoshi Ohyanagi | Author(s): Jun Shiihara, Fumiaki Kudo, Yoshiko Mizushina, Hiromitsu Ota, Shinichiro Koyama
- Abstract
Loading... -
+
P3.01-80 - Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients with NSCLC Harboring EGFR Mutations.
12:00 - 13:30 | Presenter: Naoko Okura | Author(s): Tadaaki Yamada, Akihiro Yoshimura, Takayuki Takeda, Yutaka Kubota, Shinsuke Shiotsu, Osamu Hiranuma, Junji Uchino, Koichi Takayama
- Abstract
Loading... -
+
P3.01-81 - Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Byung Jo Park | Author(s): Tae Ho Kim, Junghee Lee, Sumin Shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Young Mog Shim, Jhingook Kim
- Abstract
Loading... -
+
P3.01-82 - Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Ji Young Park | Author(s): Seung Hun Jang, Hwan Il Kim, Joo-Hee Kim, Sunghoon Park, Yong Il Hwang, Ki-Suck Jung
- Abstract
Loading... -
+
P3.01-83 - Use of Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus in Preclinical Models of NSCLC
12:00 - 13:30 | Presenter: Manish Patel | Author(s): Blake A. Jacobson, Yan Ji, Robert A. Kratzke
- Abstract
Loading... -
+
P3.01-84 - The Association of CDKN2A Gene Mutation with Clinicopathological Features and Prognosis in Advanced Lung Cancer Patients
12:00 - 13:30 | Presenter: Xiujuan Qu | Author(s): Ling Xu, Xiaowei He, Huiming Zhou, Yunpeng Liu
- Abstract
Loading... -
+
P3.01-85 - Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations - Serbian Single Center Experience
12:00 - 13:30 | Presenter: Davorin Radosavljevic | Author(s): Jelena Spasic, Marija Ristic, Vladimir Nikolic, Neda Nikolic, Nemanja Stanic, Fedja Djordjevic, Dusica Gavrilovic
- Abstract
Loading... -
+
P3.01-86 - Treatment Outcomes with Reduced Frequency of Nivolumab Dosing as Second-Line Therapy in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Shabnam Rehman | Author(s): Austin Miller, Allison Meagher, Hongbin Chen, Grace K Dy
- Abstract
Loading... -
+
P3.01-88 - Clinical and Molecular Analysis of Long-Term Survivors with Advanced Non-Small Cell Lung Cancer: A Multicenter Experience in Madrid
12:00 - 13:30 | Presenter: María Sereno Moyano | Author(s): Sandra Falagan, Juan Moreno Rubio, Rosa Álvarez Álvarez, Maria Eugenia Olmedo, Xabier Mielgo, Fátima Navarro, Ricardo Ramos, Ana Belen Enguita, Amparo Benito, María Cebollero, Isabel Alemany, Carolina Castillo, Enrique Casado, Santiago Ponce Aix
- Abstract
Loading... -
+
P3.01-89 - Upfront Surgery Versus Neoadjuvant Treatment Followed by Surgery in Pathologic N2 Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Byoung Yong Shim | Author(s): Sung Kyoung Kim, Hyung Soon Park, Kyu Do Cho, Deog Gon Cho, Young Ha Park, Jinyoung Yoo, Sung Hwan Kim, Jeong Min Ko, Eun Jung Park, Gyu Rim Heo, Chi Hong Kim
- Abstract
Loading... -
+
P3.01-90 - A Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev
12:00 - 13:30 | Presenter: Satoshi Shoji | Author(s): Satoshi Watanabe, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Satoru Miura, Masaaki Okajima, Tetsuya Abe, Hiroshi Tanaka, Junta Tanaka, Hirohisa Yoshizawa, Hiroshi Kagamu, Toshiaki Kikuchi
- Abstract
Loading... -
+
P3.01-91 - Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape
12:00 - 13:30 | Presenter: George R. Simon | Author(s): Viralkumar Bharatbhai Vaghani, Sheenu Chandwani, Meita Hirschmann, Seydeh Dibaj, Lara Lacerda Landry, Emily Roarty, Jianjun Zhang, Waree Rinsurnogkawong, Jeff Lewis, Jack Lee, Jack A Jack A. Roth, Stephen Swisher, John V Heymach, Thomas Burke
- Abstract
Loading... -
+
P3.01-92 - Blood Test Parameters as Prognostic Factors In EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs
12:00 - 13:30 | Presenter: Jelena Spasic | Author(s): Nemanja Stanic, Fedja Djordjevic, Vera Jokic, Davorin Radosavljevic
- Abstract
Loading... -
+
P3.01-93 - Osimertinib-Related Hematological and Pulmonary Toxicities in Advanced NSCLC Patients: Combined Analysis of Phase III Trials
12:00 - 13:30 | Presenter: Sriman Swarup | Author(s): Kyaw Zin Thein, Somedeb Ball, Miguel Quirch, Yuttiwat Vorakunthada, Anita Sultan, Fred Hardwicke, Lukman Tijani, Sanjay Awasthi
- Abstract
Loading... -
+
P3.01-94 - Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Konstantinos Syrigos | Author(s): Andriani Charpidou, Dimitra Grapsa, Dimitrios Vassos, Sotirios Tsimpoukis, Sofia Tsagouli, Ioannis Gkiozos
- Abstract
Loading... -
+
P3.01-95 - EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Konstantinos Syrigos | Author(s): Sofia Tsagouli, Ioannis Gkiozos, Maria Paraskeva, Ilias Kotteas, Sotirios Tsimpoukis, Marios Zontanos, Dimitra Grapsa
- Abstract
Loading... -
+
P3.01-96 - Clinical Characteristics of Non–Small Cell Lung Cancer Harboring Mutations in Exon 20 Of EGFR or HER2
12:00 - 13:30 | Presenter: Masayuki Takeda | Author(s): Kazuko Sakai, Hidetoshi Hayashi, Kaoru Tanaka, Junko Tanizaki, Takayuki Takahama, Koji Haratani, Kazuto Nishio, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P3.01-97 - Which is Better Prognostic Factor, PS, Inflammatory Marker, or PD-L1 Expression in Treating NSCLC with Nivolmab; A Retrospective Analysis
12:00 - 13:30 | Presenter: Akihiro Tamiya | Author(s): Yoshihiko Taniguchi, Yuji Inagaki, Nobuhiko Saijo, Yoko Naoki, Kenji Otsuka, Kyoichi Okishio, Takahiko Kasai, Shinji Atagi
- Abstract
Loading... -
+
P3.01-99 - Effect of Pembrolizumab on Patients Harboring Uncommon Epidermal Growth Factor Receptor Mutations
12:00 - 13:30 | Presenter: Yoshihiko Taniguchi | Author(s): Akihiro Tamiya, Yuji Inagaki, Nobuhiko Saijo, Yoko Naoki, Kenji Otsuka, Keiko Nakao, Kyoichi Okishio, Shinji Atagi
- Abstract
Loading...
-
+
P3.03 - Biology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.03-01 - BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer
12:00 - 13:30 | Presenter: Yang Gao | Author(s): Ruimin Chang, Jiaojiao Huan, Xiaoxiong Xiao, Yongchang Liu, Yanwu Zhou, Linfeng Li, Yuanda Cheng, Chunfang Zhang, Pingping Dai, Yanfang Guan, Xin Yi, Xuefeng Xia, Ling Yang
- Abstract
Loading... -
+
P3.03-02 - Single-Cell RNA-Seq in Human Lung Cancer
12:00 - 13:30 | Presenter: Jinhong Kim | Author(s): Zhaolin Xu, Paola A Marignani
- Abstract
Loading... -
+
P3.03-03 - Differential Microbiota Features in Lung Tumor and Adjacent Normal Tissues in Lung Cancer Patients
12:00 - 13:30 | Presenter: Qixing Mao | Author(s): Jianzhong Hu
- Abstract
Loading... -
+
P3.03-04 - Is the Ciliary Function of the Lesion Bronchus Maintained in Patients with Lung Cancer?
12:00 - 13:30 | Presenter: Toshiyuki Sawa | Author(s): Tsutomu Yoshida, Takashi Ishiguro, Akane Horiba, Yohei Futamura, Shigekuni Hosogi, Takashi Nakahari
- Abstract
Loading... -
+
P3.03-05 - Comparative Transcriptomic Analysis of Lung-iPSC, NSCLC, and SCLC: Potential Implications for iPSC Modeling of Lung Cancer
12:00 - 13:30 | Presenter: Vivek Shukla | Author(s): Kaitlin C McLoughlin, James Gao, Yonghong Wang, Julie Hong, Mary Zhang, Lisa Gesumaria, Haobin Chen, David S Schrump
- Abstract
Loading... -
+
P3.03-06 - Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes
12:00 - 13:30 | Presenter: Tomas Tokar | Author(s): Chiara Pastrello, Varune R. Ramnarine, Chang-Qi Zhu, Kenneth J. Craddock, Larrisa A. Pikor, Emily A. Vucic, Simon Vary, Frances A Shepherd, Ming Sound Tsao, Wan Lam, Igor Jurisica
- Abstract
Loading... -
+
P3.03-07 - Co-Occurring Genomic Alterations in EGFR Altered Chinese Lung Adenocarcinoma Patients
12:00 - 13:30 | Presenter: Minghui Wang | Author(s): Hong Zhong, Lei Dai, Lei Wang, Peng Shen, Yu Wang, Da Jiang, Min Zheng, Duoguang Wu, Fang Shi, Kefeng Wang, Chunjie Li, Hui Chen, Yu-An Dong, Weiwei Shi, Kai Wang, Ming Yao
- Abstract
Loading... -
+
P3.03-08 - Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients
12:00 - 13:30 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yunjian Huang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P3.03-09 - Molecular Spectrum of KIT Mutations Detection in Chinese Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P3.03-10 - Transcriptomic Differences Between Early and Late Stage Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Dongsheng Yue | Author(s): Bin Zhang, Rui Lin, Nan Li, Tao Wang, Liuwei Gao, Chen Chen, Changli Wang
- Abstract
Loading... -
+
P3.03-11 - Lung Cancer Stem Cells on Immune Modulation in Tumorous Microenvironment
12:00 - 13:30 | Presenter: Huei-Wen Chen | Author(s): Sheng-Fang Su, Jeremy JW Chen, Hsuan-Yu Chen, Ming-Fang Wu, Chao-Chi Ho
- Abstract
Loading... -
+
P3.03-12 - Cyclic Mechanical Strain and Myoferlin Modulates Lung Adenocarcinoma Cell Proliferation and Erlotinib Resistance
12:00 - 13:30 | Presenter: YouJin Cho | Author(s): Chris Bobba, Vasudha Shukla, Joshua Englert, Samir N Ghadiali
- Abstract
Loading... -
+
P3.03-13 - Downregulation of miRNA-506 Mediates EGFR-TKI Resistance Through Inducing Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines
12:00 - 13:30 | Presenter: Inamul Haque | Author(s): Mukut Sharma, Andrew Godwin, Chao H Huang
- Abstract
Loading... -
+
P3.03-14 - Downregulation of FOXM1 Inhibits Tumor Proliferation, Colony Formation and Spheroid Formation of Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Yoichi Otaki | Author(s): Paul Yenerall, Boning Gao, Michael Peyton, Kimberley Avila, Luc Girard, Long Shan Li, Amit Das, Kenneth Huffman, Brenda Timmons, Hyunsil Park, Dhruba Deb, John D Minna
- Abstract
Loading... -
+
P3.03-15 - Lung Cancer Regulation of Glucose Metabolic Stress Response
12:00 - 13:30 | Presenter: Laila C Roisman | Author(s): Tali Feinberg, Maya Ilouze, Nir Peled
- Abstract
Loading... -
+
P3.03-16 - 3D Morphometric Detection of Mismatch Repair Deficiency in Human Lung Adenocarcinoma Cell Lines using the Cell-CT® Platform
12:00 - 13:30 | Presenter: Daniel J Sussman | Author(s): Laimonas Kelbauskas, Michael Meyer, Rahul Katdare, Alan Nelson
- Abstract
Loading... -
+
P3.03-17 - Roles of α7nAchR Signaling in Lung Cancer
12:00 - 13:30 | Presenter: Yu-Feng Wei
- Abstract
Loading... -
+
P3.03-18 - Collagen Type XI Promotes Lung Adenocarcinoma Dissemination Via Integrin α2 and DDR1
12:00 - 13:30 | Presenter: Cédric Zeltz | Author(s): Roya Navab, Melania Pintilie, Ming Sound Tsao
- Abstract
Loading... -
+
P3.03-19 - The Lysyl Oxidase like-1 Promotes NSCLC Tumorigenecity Through Increased Matrix Reorganization and Stiffness
12:00 - 13:30 | Presenter: Cédric Zeltz | Author(s): Elena Pasko, Roya Navab, Ming Sound Tsao
- Abstract
Loading... -
+
P3.03-20 - Circulating Tumor Cell Clustering in Vitro Short-Term Culture Correlates with Poor Survival and Allows Monitoring Response to Treatment
12:00 - 13:30 | Presenter: Govind Babu K | Author(s): Deepak Koppaka, Ajay Balakrishnan, Prashant Kumar
- Abstract
Loading... -
+
P3.03-21 - CXCR4 Overexpression is Associated with Poor Survival Outcome After Recurrence in Early Stage Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Andrea Fung | Author(s): Karen Kopciuk, Michelle Dean, Adrijana D'Silva, Shannon Mary Otsuka, Alexander Klimowicz, Desiree Hao, Donald Morris, Gwyn Bebb
- Abstract
Loading... -
+
P3.03-22 - IL-1β as a New Early Predictive Biomarker for Non-Small Cell Lung Cancers Outcome
12:00 - 13:30 | Presenter: Carlotta Giorgi | Author(s): Sonia Missiroli, Nicola Tamburini, Mariasole Perrone, Pio Maniscalco, Roberta Gafà, Giovanni Lanza, Paolo Pinton, Giorgio Cavallesco
- Abstract
Loading... -
+
P3.03-23 - A Propensity Score Matching Cohort Study on Prognosis of the Diversity of MUC1 Expression in Patients with Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Chundong Gu | Author(s): Zhao Shilei, Lei Zhao, Tao Guo, Peng Wang
- Abstract
Loading... -
+
P3.03-24 - Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging
12:00 - 13:30 | Presenter: Greg J. Haro | Author(s): Johannes R. Kratz, Nancy R. Cook, Jianxing He, Stephen K. Van Den Eeden, Gavitt A. Woodard, Matthew A. Gubens, Thierry M. Jahan, Kirk D. Jones, Il-Jin Kim, Biao He, David Mark Jablons, Michael J. Mann
- Abstract
Loading... -
+
P3.03-25 - Squamous Cell Carcinoma-Associated Bronchial Dysplasias Demonstrate Altered T-helper Lymphocyte Differentiation
12:00 - 13:30 | Presenter: Daniel T Merrick | Author(s): Elizabeth J. Donald, York E. Miller, Robert L. Keith, Moumita Ghosh, Dara L. Aisner, Kimberly Jordan, Wilbur A. Franklin, James Degregori
- Abstract
Loading... -
+
P3.03-26 - Tumor Immune Microenvironment in NSCLC is Predictive of Prognosis After Surgery
12:00 - 13:30 | Presenter: Åsa Öjlert | Author(s): Ann Rita Halvorsen, Ole Christian Lindgjærde, Steinar Solberg, Odd Terje Brustugun, Åslaug Helland
- Abstract
Loading... -
+
P3.03-27 - Somatic BRCA1/2 Mutations in Advanced NSCLC Patients: Description of a Sub-Population from the Ongoing Unicancer SAFIR02-Lung / IFCT-1301 Trial
12:00 - 13:30 | Presenter: Jordi Remon | Author(s): Etienne Rouleau, Fabrice Barlesi, Alexandra Leary, Ivan Bièche, Bastien Job, Ludovic Lacroix, Aurélie Auguste, Marjorie Mauduit, Clarisse Audigier-Valette, Judith Raimbourg, Anne Madroszyk, Stefan Michiels, Mohammed Amine Bayar, Marta Jimenez, Jean-Charles Soria, Benjamin Besse
- Abstract
Loading... -
+
P3.03-28 - LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Piyada Sitthideatphaiboon | Author(s): Ana Galan Cobo, Alissa Poteete, Fahao Zhang, Diane Lui, Waree Rinsurongkawong, John V Heymach
- Abstract
Loading... -
+
P3.03-29 - The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hadas Sorotsky | Author(s): Michael Cabanero, Mor Moskovitz, Jessica Weiss, Melania Pintilie, Natasha B Leighl, Penelope Bradbury, Geoffrey Liu, Alborz Kia, Trevor J. Pugh, Dax Torti, Jonathon Torchia, Ming Sound Tsao, Frances A Shepherd
- Abstract
Loading... -
+
P3.03-30 - Clinical Significance of Urothelial Carcinoma Associated 1 in Lung Cancer
12:00 - 13:30 | Presenter: Hongyu Wu
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.04-01 - Combined Plasma cfDNA Mutations and a Serum Proteomic Signature may Identify Non-Responders to Anti PD-1 Treatment in NSCLC
12:00 - 13:30 | Presenter: Arno Amann | Author(s): Gabriele Gamerith, Alexander Bader, Westen Hahn, Cherie Tschida, Tristin Wolff Cope, Audrey Audetat, Hestia Mellert, Gary Pestano, Heinz Zwierzina
- Abstract
Loading... -
+
P3.04-02 - Early Plasma ctDNA Response Anticipates Clinical Response to First-Line Immunotherapy in Advanced NSCLC
12:00 - 13:30 | Presenter: Mark M. Awad | Author(s): Christine A Lydon, Anika Adeni, Safiya Subegdjo, Greg Jones, Vincent Plagnol, John Beeler, Geoffrey R. Oxnard
- Abstract
Loading... -
+
P3.04-03 - Association of Functional Polymorphism in CTLA-4 Gene with Survival in Non-Small Cell Lung Cancer: A Brazilian Study
12:00 - 13:30 | Presenter: Marcelo L. Balancin | Author(s): Juliana Machado-Rugolo, Alexandre Todorovic Fabro, Edwin Roger Parras Cuentas, Vanessa Karen De Sá, Claudia Aparecida Rainho, Maria Aparecida Nagai, Vera Luiza Capelozzi
- Abstract
Loading... -
+
P3.04-04 - Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients with Surgically Resected Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Xu Wang | Author(s): Xiao Ding, Jiuwei Cui
- Abstract
Loading... -
+
P3.04-05 - Programmed Death-Ligand 1 of Cytology Specimens as a Promising Method for Maker Evaluation in Patients of Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Zhengwei Dong
- Abstract
Loading... -
+
P3.04-06 - Prognostic Significance of Serum CXCL12 Level in Patients with Surgical Resected Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Jung-Jyh Hung | Author(s): Wen-Hu Hsu
- Abstract
Loading... -
+
P3.04-07 - Correlation Between PD-L1 Expression and Expression of CDK4 and SPOP in Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Masaaki Inoue | Author(s): Junichi Yoshida, Soichi Oka, Yohei Honda, Daisei Yasuda
- Abstract
Loading... -
+
P3.04-08 - Identifying Resistance to Immune Checkpoint Inhibitors by Screening for PD-L1 and MHC I Expression on CTCs in Pts with NSCLC
12:00 - 13:30 | Presenter: Ticiana A. Leal | Author(s): Jennifer L. Schehr, Alexander Kamisnki, Toby Campbell, Anne Traynor, Joshua M Lang
- Abstract
Loading... -
+
P3.04-09 - Analysis of Repertoire Features of T Cell Receptor in Treat-Naïve EGFR Wild-Type Lung Cancer Patients by High-Throughput Sequencing
12:00 - 13:30 | Presenter: Yangyang Liu | Author(s): Kai Zhang, Wenting Chen, Li Liu
- Abstract
Loading... -
+
P3.04-10 - Monocytes and Neutrophils as Predictive Markers of Response to Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Kaushal Parikh | Author(s): Arun Kumar, Jibran Ahmed, Asad Anwar, Carmelo Puccio, Hoo Chun, Michael Fanucchi, Seah Lim
- Abstract
Loading... -
+
P3.04-11 - The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
12:00 - 13:30 | Presenter: Nir Peled | Author(s): Roxana Denisa Grinberg, Laila C Roisman, Smadar Geva, Martina Lefterova, Katie Quinn, Lior Soussan Gutman, Addie Dvir, Roi Yair, Tal Twito, Richard B Lanman
- Abstract
Loading... -
+
P3.04-12 - Prognostic and Predictive Role of Peripheral Blood Biomarkers in NSCLC Patients Treated with Checkpoint, a Single-Center Experience.
12:00 - 13:30 | Presenter: Domenico Galetta | Author(s): Arsela Prelaj, Pamela Pizzutilo, Michele Montrone, Flavio Cassano, Francesco Pesola, Vittoria Lapadula, Patrizia Petrillo, Nciccolo Varesano, Vito Lamorgese, Angelica Mastrandrea, Donatella Ricci, Annamaria Catino
- Abstract
Loading... -
+
P3.04-13 - PD-L1-Gene Expression by nCounter Correlates with PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
12:00 - 13:30 | Presenter: Noemi Reguart | Author(s): Carlos Cabrera, Cristina Aguado, Cristina Teixido, Laia Pare, Josep Castellvi, L. López, Elba Marin, Xana Bernal, Daniel Martinez, Ana Giménez-Capitán, Nuria Vinolas, Zaira Yeste, Nuria Baixeras, Ruth Roman, Miguel-Angel Molina-Vila
- Abstract
Loading... -
+
P3.04-14 - TMB and Immune Checkpoint Inhibitor Gene Expression are Unrelated in NSCLC Patients
12:00 - 13:30 | Presenter: Christopher Wae Keong Szeto | Author(s): Rahul Parulkar, Chad Garner, Sandeep Bobby Reddy
- Abstract
Loading... -
+
P3.04-15 - IDO and Tim3 Gene Expression is Correlated in NSCLC Patients with Low PDL1 Gene Expression
12:00 - 13:30 | Presenter: Christopher Szeto | Author(s): Rahul Parulkar, John Lee, Chad Garner, Sandeep Bobby Reddy
- Abstract
Loading... -
+
P3.04-16 - A Seven-Gene Expression Signature Reveals Unique Immune-Phenotypes Related to Major Oncogenic-Drivers in NSCLC
12:00 - 13:30 | Presenter: Cristina Teixido | Author(s): Laia Pare, Cristina Aguado, Sandra Lopez, Ana Giménez-Capitán, Andrés F. Cardona, Carlos Cabrera, Sergi Castillo, Mónica Garzón, Clara Mayo, Ivana Sullivan, Silvia Muñoz, Giancarlo Castellano, Pedro Jares, Aleix Prat, Miguel-Angel Molina-Vila, Noemi Reguart
- Abstract
Loading... -
+
P3.04-17 - Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada
12:00 - 13:30 | Presenter: Umang Ondhia | Author(s): Henry Conter, Scott Owen, Anna Zhou, Julian Nam, Sumeet Singh, Ahmed Abdulla, Paula Chu, Federico Felizzi, Randeep Sangha
- Abstract
Loading... -
+
P3.04-18 - The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
12:00 - 13:30 | Presenter: YiMing Weng | Author(s): Min Peng, Yi Yao, Qibin Song
- Abstract
Loading... -
+
P3.04-19 - Do Advanced Lung Cancer Patients Derive Similar Survival Benefits from Immunotherapy? A Systematic Review and Meta-Analysis
12:00 - 13:30 | Presenter: Jacques Raphael | Author(s): Anupam Batra, Gabriel Boldt, Prakeshkumar Shah, Phillip Blanchette, George Rodrigues, Mark David Vincent
- Abstract
Loading... -
+
P3.04-20 - Correlation of Immune-Related Adverse Events and Response from Immune Checkpoint Inhibitors in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Mike Sung | Author(s): Alona Zer, Preet Walia, Leila Khoja, Manjula Maganti, Catherine Labbe, Frances A Shepherd, Penelope Bradbury, Geoffrey Liu, Natasha B Leighl
- Abstract
Loading... -
+
P3.04-21 - Antibiotics Attenuate the Clinical Benefit of Anti-PD-(L)1 Immunotherapies in Chinese Patients with Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Sha Zhao | Author(s): Yijun Jia, Tao Jiang, Xuefei Li, Wei Li, Guanghui Gao, Chao Zhao, Yayi He, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P3.04-22 - Response of Brain Metastases in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy and Brain Directed Radiotherapy
12:00 - 13:30 | Presenter: Alessandra Curioni Fontecedro | Author(s): Dilara Akhoundova Sanoyan, Martin Hüllner, Johannes Kraft, Lorenz Bankel, Seok-Yun Lee, Nicolaus Ansratschke
- Abstract
Loading... -
+
P3.04-23 - Phase 1b/2 Study to Evaluate Novel Combinations With Oleclumab (MEDI9447) in Previously Treated Advanced EGFRm NSCLC
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Catherine Shu, Sarah B Goldberg, Vassiliki A Papadimitrakopoulou, Ross Camidge, Sandip Patel, Kristen A. Marrone, Sang-We Kim, Dong-Wan Kim, Hsin-ju Hsieh, Nancy Mueller, Rakesh Kumar, Judson Englert, Keunchil Park
- Abstract
Loading... -
+
P3.04-24 - EMPOWER-Lung 2: Cemiplimab and Ipilimumab ± Chemotherapy vs Pembrolizumab in Advanced NSCLC with PD-L1 ≥50%, a Phase 3 Study
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading... -
+
P3.04-25 - EMPOWER-Lung 3: A Phase 3 Study of Cemiplimab, Ipilimumab and Chemotherapy in Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading... -
+
P3.04-26 - EMPOWER-Lung 4: A Phase 2 Study of Cemiplimab Plus Ipilimumab in the Second-Line Treatment of Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading... -
+
P3.04-27 - An Allogeneic Tumor Cell Lysate Vaccine Induces Immune Responses to Lung Cancer Associated Antigens: Preliminary Results of a Phase II Study
12:00 - 13:30 | Presenter: David S Schrump | Author(s): Mary Zhang, Julie Hong, Tricia Kunst, Colleen Bond, Javier Yeray, Min-Jung Lee, Akira Yuno, Sunmin Lee Lee, Li Xia, Cara Kenney, Cheryl Warga, Tania Guerrero, Taylor Ripley, Chuong Hoang, Sacha Gnjatic, Jeffrey Gildersleeve, Jane Trepel
- Abstract
Loading... -
+
P3.04-28 - Can Ipilimumab Restore Immune Response in Advanced NSCLC After Progression on Anti PD1/PDL1 Agents?
12:00 - 13:30 | Presenter: Michal Sternschuss | Author(s): Nir Peled, Elizabeth Dudnik, Ofer Rotem, Alona Zer
- Abstract
Loading... -
+
P3.04-29 - Efficacy of Re-Treatment with Immune Checkpoint Inhibitors in Patients with Pretreated Advanced Non-Small Cell Lung Carcinoma
12:00 - 13:30 | Presenter: Takayuki Takahama | Author(s): Masayuki Takeda, Koji Haratani, Kaoru Tanaka, Hidetoshi Hayashi, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
P3.07 - Nursing and Allied Professionals (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.07-01 - Telephone Preassessment Clinic Incorporating Holistic Needs
12:00 - 13:30 | Presenter: Vanessa Karen Beattie | Author(s): Paula Shepherd, Maria Guerin
- Abstract
Loading... -
+
P3.07-02 - Expectations, Standards and Performance Framework to Support the Lung Cancer Support Nurse in Lung Foundation Australia
12:00 - 13:30 | Presenter: Vanessa Nicole Brunelli | Author(s): Claire Mulvihill, Jane Kerr, Heather Allan
- Abstract
Loading... -
+
P3.07-03 - Lung Cancer Clinical Nurse Specialist & Palliative Care Nurse Specialist – A Dual Role
12:00 - 13:30 | Presenter: Karen Jane Clayton | Author(s): Andrea Byatte, Natalie Barnett, Charlotte Guerin
- Abstract
Loading... -
+
P3.07-04 - Massage Chair Encounters Favorably Impact Outpatient Oncology RN’s Perceived Level of Stress, BP, HR
12:00 - 13:30 | Presenter: Mary Ellen Hand | Author(s): Samantha Duveneck, Jennifer Margolis, Mary Zindrick, Jozel Baptista, Katharine Ruestow, Beth Staffileno, Phd, Faha, Sylwia Potoczny
- Abstract
Loading... -
+
P3.07-05 - Can Improving Working Partnerships with Primary Care Prevent Avoidable Emergency Admissions for Patients with Lung Cancer?
12:00 - 13:30 | Presenter: June Carol Morley | Author(s): V Anderson, Vanessa Karen Beattie, Karen Clayton, Donna Denby, Marie Eaton, Sue Glover, Angela Griffiths, Nicola Maddock, Julia McAdam, Sarah Morgan, Tiffany Perkins, Sophie Phillips, Bethan Pugh, Patricia Rees, Josie Roberts, Will Robinson, Pamela Rose
- Abstract
Loading... -
+
P3.07-06 - Receiving a Diagnosis Of MESOthelioma (RADIO Meso): Recommendations for Practice to Improve the Patient Experience
12:00 - 13:30 | Presenter: Bethany Taylor | Author(s): Angela Mary Tod, Hannah Ball, Liz Darlison, Helena Stanley, Clare Warnock
- Abstract
Loading... -
+
P3.07-07 - Multidisciplinary Supportive Care Assessment in Lung Cancer – A Case Study Example
12:00 - 13:30 | Presenter: Faye Louise Dickinson | Author(s): Ceri Childs, Rhys White, Pippa Labuc
- Abstract
Loading... -
+
P3.07-08 - Pain Management in Lung Cancer
12:00 - 13:30 | Presenter: Abdallah El Meziane | Author(s): Hanane Laarej
- Abstract
Loading... -
+
P3.07-09 - Characterization of the Nutritional Status in Lung Cancer Patients: A Retrospective Study
12:00 - 13:30 | Presenter: Henrique Queiroga | Author(s): Marta Rola, Ana Barreira, Rosário Ataíde, Cláudia Dias, Diana Silva
- Abstract
Loading... -
+
P3.07-10 - What Do People Living with Lung Cancer Want and Need from the Recovery Package
12:00 - 13:30 | Presenter: Josie Roberts | Author(s): Angela Mary Tod, Ferzanah Salim, Philippa Collins, Vicky Athey
- Abstract
Loading... -
+
P3.07-11 - Survivorship After Lung Cancer Surgery – SOLACE – A Macmillan Funded Project
12:00 - 13:30 | Presenter: Charlotte Merriman | Author(s): Jane Canavan, Jenny Mitchell, Elizabeth Belcher, Dionisios Stavroulias, Francesco Di Chiara
- Abstract
Loading... -
+
P3.07-12 - Improving Cardiac Tamponade Outcomes Through Less Invasive Interventions and Earlier Recognition
12:00 - 13:30 | Presenter: Kristie Murphy
- Abstract
Loading... -
+
P3.07-13 - Non-Oncology Provider Immunotherapy Needs Assessment
12:00 - 13:30 | Presenter: Enza Nguyen | Author(s): Lavinia Dobrea
- Abstract
Loading... -
+
P3.07-14 - Collaborations of Pharmacists with Lung Cancer Treatment by Prepared Patients Controlled Analgesia (PCA) for Perioperative Pain Control
12:00 - 13:30 | Presenter: Kumiko Tani | Author(s): Hitoshi Houchi, Shinji Kosaka, Masato Kaji, Shigeko Tsuji, Kazuko Higuchi, Yoshie Isobe, Yuki Honda, Mai Kouzai, Sayaka Yamashita
- Abstract
Loading...
-
+
P3.08 - Oligometastatic NSCLC (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.08-01 - Treatment Outcomes in Oligometastatic Disease of Non Small Cell Lung Cancer: A Single Center Experience
12:00 - 13:30 | Presenter: Pınar Akın Kabalak | Author(s): Derya Kızılgöz, Ülkü Yılmaz, Tuba İnal Cengiz, Evrim Tunç, Şebnem Yaman, Erkmen Gülhan
- Abstract
Loading... -
+
P3.08-02 - Oligometastatic Non Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT), a Single Institution Experience
12:00 - 13:30 | Presenter: Davide Franceschini | Author(s): Fiorenza De Rose, Gianluca Radicioni, Eno Toska, Lidia Faraci, Giulio Carta, Marta Scorsetti
- Abstract
Loading... -
+
P3.08-03 - Stereotactic Radiotherapy of Lung Cancer with Synchronous Bilateral Noduli or Oligometastatic Disease
12:00 - 13:30 | Presenter: Tine Schytte | Author(s): Olfred Hansen, Charlotte Kristiansen, Stefan Starup Jeppesen, Tine Bjørn Nielsen, Morten Nielsen
- Abstract
Loading... -
+
P3.08-04 - OMEGA, A Randomized Trial of Local Ablative Therapy Vs. Conventional Treatment in Oligometastatic NSCLC – Trial in Progress
12:00 - 13:30 | Presenter: Maurizio Infante | Author(s): Emilio Bria, Silvia Novello, Ugo Pastorino, Lucio Buffoni, Marta Scorsetti, Marco Alloisio, Andrea Ardizzoni, Antonio Santo, Sara Pilotto, Francesco Facciolo, DIANA Giannarelli
- Abstract
Loading... -
+
P3.08-05 - Stereotactic Body Radiation Therapy (SBRT) Outcomes in Elderly Patients with Lung Oligometastases
12:00 - 13:30 | Presenter: Luis Larrea | Author(s): Paola Antonini, Enrique López, Verónica González, José Bea, Mª Carmen Baños
- Abstract
Loading... -
+
P3.08-06 - Long-Term Survival for Brain-Only Oligometastatic NSCLC Patients Treated with Ablative Therapy (AT): Prognostic Factors
12:00 - 13:30 | Presenter: Óscar Juan-Vidal | Author(s): Carmen Salvador Coloma, Corina Escoin, David Lorente, Juan Antonio Mendez
- Abstract
Loading... -
+
P3.08-07 - An Institution Review of Outcomes of Lung Stereotactic Body Radiotherapy in Various Oligometastatic Disease States
12:00 - 13:30 | Presenter: Brendan Seng Hup Chia | Author(s): Wee Loon Ng, Swee Peng Yap, Kevin Lee Min Chua, Connie Yip, Anuradha Thiagarajan, Tian Rui Siow, Kam Weng Fong
- Abstract
Loading... -
+
P3.08-08 - Outcomes of Pulmonary Metastasectomy in Breast Cancer: Prognosis Based on the Metastatic Lung Tumor Study Group of Japan
12:00 - 13:30 | Presenter: Makoto Endoh | Author(s): Satoshi Shiono, Noriyuki Matsutani, Sakae Okumura, Norihiko Ikeda, Ichiro Yoshino, Jun Nakajima, Masafumi Kawamura
- Abstract
Loading... -
+
P3.08-09 - Surgical Resection of Pulmonary Oligo-Recurrence of Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Yoshitaka Kitamura | Author(s): Wataru Nishio, Yuuki Nishioka, Hiroki Tanaka, Hiroyuki Ogawa, Shinya Tane, Masahiro Yoshimura
- Abstract
Loading... -
+
P3.08-10 - A Retrospective Study of Oligo-Recurrence in Patients with Resected Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Taku Nakagawa | Author(s): Satoshi Kudo, Shinogu Takashima, Hidenobu Iwai, Haruka Suzuki, Yoshihiro Minamiya
- Abstract
Loading... -
+
P3.08-11 - Differences in Evaluations of Early Thorax CT’s Post Lung Stereotactic Body Radiotherapy (SBRT)
12:00 - 13:30 | Presenter: Fazilet Oner Dincbas | Author(s): Meltem Dagdelen, Emine Sedef
- Abstract
Loading... -
+
P3.08-12 - Long-Term Outcome After Adrenalectomy for Isolated Adrenal Metastasis in Otherwise Operable Patients With NSCLC - Two Institutions Study
12:00 - 13:30 | Presenter: Danail Borisov Petrov | Author(s): Anatoli Semkov, Dejan Djuric, Emilia Naseva, Georgi Yankov, Svetlana Shumarova, Georgi Todorov
- Abstract
Loading... -
+
P3.08-13 - Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
12:00 - 13:30 | Presenter: Rodney Wegner | Author(s): Nissar Ahmed, Shaakir Hasan, Lana Schumacher, Athanasios Colonias
- Abstract
Loading... -
+
P3.08-14 - Long-Term Survival Following Surgical Resection of Isolated Brain Metastasis in Non-Small Cell Lung Cancer.
12:00 - 13:30 | Presenter: Wen-jui Wu | Author(s): Chiate Yen
- Abstract
Loading... -
+
P3.08-15 - Lung Squamous Cell Carcinoma with Solitary Ocular Metastasis,Successful Treatment: An Interesting and Rare Case Report
12:00 - 13:30 | Presenter: Ye Guo | Author(s): Kewei Ma, Xu Wang, Yinghui Xu
- Abstract
Loading... -
+
P3.08-16 - Prognostic Value of PDL-1 Expression and Correlation Between Primary Tissue and Brain Metastases in Oligometastatic NSCLC
12:00 - 13:30 | Presenter: Vimal Krishnan | Author(s): Kassi Imane, Louis Gaboury, Roula Albadine, Danh Tran-Thanh, Camille Gauvin, Normand Blais, Bertrand Routy, Mustapha Tehfe, Marie Florescu
- Abstract
Loading... -
+
P3.08-17 - Paediatric Motion Management Solutions for Particle Therapy Based Thoracic Stereotactic Ablative Body Radiotherapy (SABR)
12:00 - 13:30 | Presenter: Fiona Hegi-Johnson | Author(s): Aaron Kent, Nicholas Hardcastle, Tomas Kron, Greg Wheeler
- Abstract
Loading... -
+
P3.08-18 - Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT
12:00 - 13:30 | Presenter: Edyta Maria Urbanska | Author(s): Linea Cecilie Melchior, Karin De Stricker, Jens Benn Sørensen, Eric Santoni Rugiu
- Abstract
Loading... -
+
P3.08-18a - MR Perfusion and Spectroscopy to Distinguish Radiation Necrosis from Tumor Progression for Brain Metastases Treated with SRS
12:00 - 13:30 | Presenter: Christel De Pooter | Author(s): Leo Vael, Emily Latacz, Walter Van Rompaey, Peter Vermeulen, Philippe Huget, Paul Meijnders, Katrien Erven
- Abstract
Loading...
-
+
P3.09 - Pathology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.09-01 - PDL1 Profile of Filipino Lung Adenocarcinoma Patients Show Moderate Positivity and Low EGFR Correlation
12:00 - 13:30 | Presenter: Francisco III Maramara Heralde | Author(s): Maria Teresa Alhambra Barzaga, Nelia Tan-Liu, Mary Suzette Angeles, Samuel Bernal
- Abstract
Loading... -
+
P3.09-02 - Utilization of Laboratory Developed Tests for PD-L1 Evaluation is Dependent on Tumor Type
12:00 - 13:30 | Presenter: Jingxin Qiu | Author(s): Ankush Chander, Boulos Beshai, Kristopher Attwood, Angela R. Omilian
- Abstract
Loading... -
+
P3.09-03 - Alteration of Gut Microbiome in Lung Cancer Patients
12:00 - 13:30 | Presenter: Jun Chen | Author(s): Ming Li, Jieli Yuan, Shu Wen
- Abstract
Loading... -
+
P3.09-04 - Assessment of PD-L1 Expression in Cytology Samples: An Anlaysis of 263 Consecutive NSCLC Biopsies.
12:00 - 13:30 | Presenter: Peter B Illei | Author(s): Ankit Rajgariah
- Abstract
Loading... -
+
P3.09-05 - Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
12:00 - 13:30 | Presenter: Cristian Ortiz -Villalón | Author(s): Luigi De Petris, Lorand Kis, Akira Yoshikawa, Hoa Ngoc, Anja C Roden, Junya Fukuoka, Angeles Montero
- Abstract
Loading... -
+
P3.09-06 - The Link Between Tumor Promoting Fibrous Microenvironment and Immunosuppressive Microenvironment in Stage I Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Takashi Sakai | Author(s): Keiju Aokage, Shinya Neri, Hiroshi Nakamura, Satoshi Okada, Tomohiro Miyoshi, Kenta Tane, Masato Sugano, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii
- Abstract
Loading... -
+
P3.09-07 - Immunohistochemical Expression of Programmed Death-Ligand 1 in Diabetic Patients vs Non-Diabetics with Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Negar Rassaei | Author(s): Michael Phillip Zaleski, Setareh Sharzehi, Rickie P Voland, John Michael Varlotto, Yongjun Liu
- Abstract
Loading... -
+
P3.09-08 - Tumor Heterogeneity and Molecular Profile of NSCLC in Thai Population
12:00 - 13:30 | Presenter: Thanyanan Reungwetwattana | Author(s): Supoj Detarkom, Pimpin Incharoen, Artit Jinawat, Narumol Trachu, Kaettipong Kamprerasart, Naiyarat Prasongsook, Piyawan Tienchainaanda, Nareenart Iemwimangsa, Krarun Sararat, Wasun Chantratita
- Abstract
Loading... -
+
P3.09-10 - Circulating Cell-Free DNA (cfDNA) Molecular Profile of Thai NSCLC Patients Using Difference Variant Frequency of NGS
12:00 - 13:30 | Presenter: Nareenart Iemwimangsa | Author(s): Narumol Trachu, Vantanit Pairoj, Angkana Charoenyingwattana, Pimpin Incharoen, Supoj Detarkom, Somthawin Lukrak, Lalida Arsa, Nanamon Monnamo, Sarunporn Techasurungkul, Thanyanan Reungwetwattana, Wasun Chantratita
- Abstract
Loading... -
+
P3.09-11 - Genomic Organization at Large Scales (GOALS) within Nuclei and Cell Sociology for Predicting Lung Cancer Outcomes
12:00 - 13:30 | Presenter: Calum Macaulay | Author(s): Martial Guillaud, Katey S.S. Enfield, Zhaolin Xu, Stephen Lam, Wan Lam, Paul Gallagher
- Abstract
Loading... -
+
P3.09-12 - Molecular and Immunohistochemical Correlates of RB1 Inactivation in Small Cell Lung Carcinoma
12:00 - 13:30 | Presenter: Navin Rajput Mahadevan | Author(s): Lynette M Sholl, David Hwang
- Abstract
Loading... -
+
P3.09-13 - Molecular Profiling Suggests the Different Mechanisms Among Local Invasiveness in Resected Human Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Toshi Menju | Author(s): Terumasa Sowa, Naoto Imamura, Shigeto Nishikawa, Koji Takahashi, Ryo Miyata, Hiroyuki Ishikawa, Misa Noguchi, Masatsugu Hamaji, Daisuke Nakajima, Akihiro Ohsumi, Toshihiko Sato, Toyofumi Fengshi Chen-Yoshikawa, Makoto Sonobe, Hiroshi Date
- Abstract
Loading... -
+
P3.09-14 - Pathobiology of Notch2 in Lung Cancer
12:00 - 13:30 | Presenter: Yamato Motooka | Author(s): Kosuke Fujino, Kazuhiro Yasufuku, Makoto Suzuki, Takaaki Ito
- Abstract
Loading... -
+
P3.09-15 - Genetic Profiling of Idiopathic Pulmonary Fibrosis Associated Non-Small Cell Lung Cancer by Targeted Next-Generation Sequencing
12:00 - 13:30 | Presenter: Kohei Otsubo | Author(s): Eiji Iwama, Kentaro Tanaka, Yoshimasa Shiraishi, Yasuto Yoneshima, Hiroyuki Inoue, Tetsuzo Tagawa, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading... -
+
P3.09-16 - Transcriptome Profiling for Subtyping NSCLC: Off the Beaten Path(Ologist)
12:00 - 13:30 | Presenter: Lars Frederick Petersen | Author(s): Adrijana D'Silva, Michelle Dean, Mie Konno, Yaroslav Ilnytskyy, Olga Kovalchuk, Gwyn Bebb
- Abstract
Loading... -
+
P3.09-17 - Molecular Profile in Lung Adenocarcinoma. A Muticenter Study in Cordoba, Argentina.
12:00 - 13:30 | Presenter: Norma Graciela Pilnik | Author(s): Veronica Bengio, Maximiliano Franco Canigiani, Pilar Diaz
- Abstract
Loading... -
+
P3.09-18 - Identification of MET exon 14 Skipping Mutations by FusionPlexTM Solid Tumor Panel
12:00 - 13:30 | Presenter: Laura J. Tafe | Author(s): Sophie Deharvengt, Jennifer Kilbourn, Donald Green, Jason Peterson, Francine De Abreu
- Abstract
Loading... -
+
P3.09-19 - Matched Thai Lung Cancer Patients Tissue and cfDNA Molecular Profile by NGS
12:00 - 13:30 | Presenter: Narumol Trachu | Author(s): Supoj Detarkom, Pimpin Incharoen, Kattipong Kamprerasart, Nareenart Iemwimangsa, Lalida Arsa, Wasun Chantratita, Dittapol Muntham, Ekaphop Sirachainan, Thanyanan Reungwetwattana
- Abstract
Loading... -
+
P3.09-20 - A Simple and Versatile Next-Generation Sequencing Technology for Co-Detection of RNA Structural Variants and DNA Mutations in Lung Cancer
12:00 - 13:30 | Presenter: Huiping Zhu | Author(s): Shobha Gokul, Gary Latham
- Abstract
Loading... -
+
P3.09-21 - Mixed Mucoepidermoid Carcinoma and Adenocarcinoma of the Lung: A Case Report and a Literature Review
12:00 - 13:30 | Presenter: Yu-Deok Choi
- Abstract
Loading... -
+
P3.09-22 - Correlation Between Maximum Tumour Diameter Measurement on CT-Scan and Histopathological Specimen: An Indian Experience
12:00 - 13:30 | Presenter: Manoj Gowda | Author(s): Babul Bansal, Vinay Kumar, Svs Deo, Sandeep Bhoriwal, Deepali Jain, Prabhat Malik, Sachidanand Jee Bharati, Sunil Kumar
- Abstract
Loading... -
+
P3.09-23 - Accuracy and Reproducibility of Touch Imprint Cytology in Resected Lung Cancer
12:00 - 13:30 | Presenter: Masatoshi Kakihana | Author(s): Masaru Hagiwara, Junichi Maeda, Yoshihisa Shimada, Sachio Maehara, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
P3.09-24 - The Concordance of Histological Diagnosis from Transbronchial Biopsy and Resected Specimen of Lung Cancers
12:00 - 13:30 | Presenter: Yoshiteru Kidokoro | Author(s): Tomohiro Haruki, Yuji Nozaka, Wakako Fujiwara, Tatsuya Miyamoto, Taichi Kadonaga, Takashi Ohno, Makoto Wakahara, Yuzo Takagi, Yuko Tanaka, Kanae Nosaka, Ken Miwa, Yoshimasa Suzuki, Yuji Taniguchi, Masahiro Kodani, Yoshihisa Umekita, Hiroshige Nakamura
- Abstract
Loading... -
+
P3.09-25 - Survival Analysis in Young Adults with Lung Carcinoma
12:00 - 13:30 | Presenter: Jessica Silva Nicolau | Author(s): Maria Aparecida Azevedo Koike Folgueira, Rosimeire Aparecida Roela, Simone Maistro, Maria Lucia Hirata Katayama, Jose Eluf Neto, Carolina Terra de Moraes Luizaga, Karina de Cassia Braga Ribeiro, Gilberto De Castro, Jr.
- Abstract
Loading... -
+
P3.09-26 - Concordance of Surgical Resections and Fine Needle Biopsy-Derived Cell Block Sections for PD-L1 22C3 Immunohistochemistry
12:00 - 13:30 | Presenter: Joerg Schwock | Author(s): Hyang Mi Ko, Jessica Weiss, Carol Cheung, Scott Boerner, Ming Sound Tsao
- Abstract
Loading... -
+
P3.09-27 - Histopathologic Parameters Define Features of Treatment Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Annikka Weissferdt | Author(s): Tina Cascone, Apar Pataer, Neda Kalhor, Cesar Moran, Mara B Antonoff, Garrett L Walsh, Chantale Bernatchez, Don Lynn Gibbons, Ignacio I. Wistuba, Jack A Roth, Jianjun Zhang, Emily Roarty, Lara Carolina Alvarez de Lacerda Landry, Ara A Vaporciyan, John V Heymach, Stephen Swisher, Boris Sepesi
- Abstract
Loading...
-
+
P3.11 - Screening and Early Detection (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.11-01 - Methylation Markers That Correlate with Occult Lymph Node Metastases of NSCLC and a Preliminary Prediction Model
12:00 - 13:30 | Presenter: Wenhua Liang | Author(s): Jinsheng Tao, Zeyu Jiang, Jianyu Sun, Jianbing Fan, Jianxing He
- Abstract
Loading... -
+
P3.11-02 - Lung Cancer Screening in a High Incidence Population: Results of Low-Dose CT Screenings in a Northern Kentucky Community Healthcare System
12:00 - 13:30 | Presenter: Royce Calhoun | Author(s): Glen Turner, Gary Schmitt, Michael Gieske, Ellen Krasik, Valerie Williams, Sara Browne, Megan Lockwood, Ellen Burns, Adrienne Snow
- Abstract
Loading... -
+
P3.11-03 - Implementing Lung Cancer Screening in Canada: Evidence on Adherence and Budget Impact from the Pan-Canadian Early Detection Study
12:00 - 13:30 | Presenter: Sonya Cressman | Author(s): Stuart James Peacock, Alain Tremblay, Cheryl Ho, Martin Tammemägi, Stephen Lam
- Abstract
Loading... -
+
P3.11-04 - Trends and Barriers in Lung Cancer Screening Implementation Across the United States.
12:00 - 13:30 | Presenter: Jennifer C King | Author(s): Angela Meredith Criswell, Andrew Ciupek, Amy Copeland
- Abstract
Loading... -
+
P3.11-05 - Use of Electronic Medical Record (EMR)-Embedded Clinical Decision Support Tools Improves Lung Cancer Screening Rates
12:00 - 13:30 | Presenter: John D Doty | Author(s): Leisa D Lackey, Jennifer L Ersek, Daniel K Howard, Amy W Clary
- Abstract
Loading... -
+
P3.11-06 - Improving Lung Cancer Screening Completion Rates in a Primary Care Practice in Large Urban Academic Medical Center
12:00 - 13:30 | Presenter: Linda Dowling | Author(s): Laura J Zimmermann, Palmi Shah, Lynda Powell, Daniel Dunham
- Abstract
Loading... -
+
P3.11-07 - The Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project
12:00 - 13:30 | Presenter: Linda Dowling | Author(s): Palmi Shah, Ramya S Gaddikeri, Ashley Levitan
- Abstract
Loading... -
+
P3.11-08 - Lung Cancer Screening at an Academic Medical Center: Early Patterns of Practice
12:00 - 13:30 | Presenter: Linda Dowling | Author(s): Jansi Willoughby, Palmi Shah, Betty Tran
- Abstract
Loading... -
+
P3.11-09 - Shared Decision Making; A Decision Aid for the Primary Practitioner
12:00 - 13:30 | Presenter: Frederic Winslow Grannis
- Abstract
Loading... -
+
P3.11-10 - Lung Cancer Screening Shared Decision Making: Decision-Aid for the Patient
12:00 - 13:30 | Presenter: Frederic Winslow Grannis | Author(s): Sheila Ross
- Abstract
Loading... -
+
P3.11-11 - Improving Timeliness of Lung Cancer Diagnostic Services with the Implementation of Coordinated Care via a “Navigation Day”
12:00 - 13:30 | Presenter: Michael Alexios Gulak | Author(s): Chantal Bornais, Salome Shin, Liane Murphy, Jennifer Smylie, Jason Pantarotto, Michael Fung-Kee-Fung, Donna E Maziak
- Abstract
Loading... -
+
P3.11-12 - Comparison of Cancer Screening Adherence According to Smoking Status: Korea National Health and Nutrition Examination Survey 2010-2012
12:00 - 13:30 | Presenter: Yong Saing Kim | Author(s): Joohwan Park, Eun Young Kim, Hee Young Lee, Hee Kyung Ahn, Shin Myung Kang, Inkeun Park
- Abstract
Loading... -
+
P3.11-13 - Liverpool Identifies the Hard to Reach Population at Risk of Developing Lung Cancer.
12:00 - 13:30 | Presenter: Martin Ledson | Author(s): Ed Gaynor, Seamus Grundy, Sarah Hill, Darcy Fidoe, Sabrina Mason, Stephen Duffy, John Kirkpatrick Field
- Abstract
Loading... -
+
P3.11-14 - Low Rates of Lung Cancer Screening Among Doctors in Mexico
12:00 - 13:30 | Presenter: Omar Macedo-Pérez | Author(s): Saul Campos-Gomez, María Isabel Enríquez-Aceves, Fernando Talavera-Caro, Iván Lyra-González, Katya Campos-Peralta, Edgardo Jiménez-Fuentes
- Abstract
Loading... -
+
P3.11-15 - Lung Cancer Symptom Perception and Intervention Preferences in the UK’s Most Deprived Communities: A Qualitative Study
12:00 - 13:30 | Presenter: Kate Brain | Author(s): Grace McCutchan, Julia Hiscock, Peter Murchie, Kerry Hood, Richard Neal, Sara Thomas, Ann Maria Thomas, Gareth Newton
- Abstract
Loading... -
+
P3.11-16 - Comparative Analysis of Health-Care Resources and Economic Costs of Lung Cancer Patients Treated Medically or Surgically in Catalunya
12:00 - 13:30 | Presenter: Laureano Molins | Author(s): Angela Guirao, Rudith Guzman, Montserrat Cleries, Emili Vela, David Magen, David Sanchez, Marc Boada, Jose A Espinas, Josep M Borras, Jose M Argimon, Alvaro Agusti
- Abstract
Loading... -
+
P3.11-18 - Implementing One Stop Lung Clinic to Improve Diagnostic Timeliness in Lung Cancer Patients in the North of England
12:00 - 13:30 | Presenter: Vytis Dudzevicius | Author(s): Spencer Robinson, Ramamurthy Sathyamurthy, Rehan Mustafa, Richard Hartley, Giedre Andrijevskiene, Kerry Linkin, Terri Jasper, Jan Hughes, Sara Fenwick, Heidi Sircus, Nigel Clerk, Rachel Shears, Andrea Charles, Carol Taylor, Kay Dover, Angela Wood
- Abstract
Loading... -
+
P3.11-19 - Improving Lung Cancer Screening Rates in an Underserved Outpatient Clinic
12:00 - 13:30 | Presenter: Carlos Armando Rodriguez | Author(s): Ana Velazquez, Alan Tso
- Abstract
Loading... -
+
P3.11-20 - Patterns and Predictors of Adherence to Recommended Follow-Up After Low-Dose Computed Tomography Screening for Lung Cancer
12:00 - 13:30 | Presenter: Lori C. Sakoda | Author(s): Cecile A Laurent, Charles P Quesenberry Jr., George Minowada
- Abstract
Loading... -
+
P3.11-21 - The Development of a Robust Radiology Quality Assurance (QA) Program in a Provincial High-Risk Lung Cancer Screening Pilot (HRLCSP)
12:00 - 13:30 | Presenter: Heidi Schmidt | Author(s): Michelle Ang, Redinela Mani, Gail Elizabeth Darling, Deanna Langer, Priyanka Jain, Victoria Treister, Martin Tammemägi, Simrun Flora
- Abstract
Loading... -
+
P3.11-22 - The Path to National Lung Cancer Screening Program in Israel
12:00 - 13:30 | Presenter: Shani Shilo | Author(s): Abed Agbaria, Nir Peled
- Abstract
Loading... -
+
P3.11-23 - Adherence to Annual Low-Dose CT Lung Cancer Screening at a Large Academic Institution
12:00 - 13:30 | Presenter: Lucy B Spalluto | Author(s): Jennifer A. Lewis, Kim L. Sandler, Pierre P Massion, Robert S. Dittus, Christianne L. Roumie
- Abstract
Loading... -
+
P3.11-24 - “To Know or Not to Know ...?” Push and Pull in Ever Smokers Lung Screening Uptake Decision Making Intentions
12:00 - 13:30 | Presenter: Janet Tonge | Author(s): Melanie Atack, Phillip Crosbie, Phil Barber, Richard Booton, Denis Colligan
- Abstract
Loading... -
+
P3.11-25 - Analysis Indicates Low Incremental Cost-Effectiveness Ratio for Implementation of Lung Cancer Screening in Italy
12:00 - 13:30 | Presenter: Giulia Veronesi | Author(s): Simone Ghislandi, Elena Vanni, Elisa Dieci, Luca Toschi, Laura Velutti, Michela Solinas, Pierluigi Novellis, Marco Alloisio, Elio Riboli, Niccolò Navone
- Abstract
Loading... -
+
P3.11-26 - Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer from a Single-Institution in China
12:00 - 13:30 | Presenter: Wei Wang | Author(s): Mimi Zhou, Jicheng Xie, Minhua Ye, Dongqing Lv, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P3.11-27 - Lung Cancer Diagnosed at Age 50-54 Years: Survival as Poor as Older Patients
12:00 - 13:30 | Presenter: Ping Yang | Author(s): Lei Luo, Yi Wang, Jason Wampfler, Dan Liu, Yuanyuan Wang, Shawn Stoddard, Yanan Yang, Hao Xie, David Midthun
- Abstract
Loading...
-
+
P3.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.12-01 - Targeting Mitochondrial Metabolism as a Selective Therapeutic Approach in Small Cell Lung Cancer (SCLC)
12:00 - 13:30 | Presenter: Shantanu Banerji | Author(s): Subir Roy Chowdhury, Ryan Saleh, Carmen Girard, Cheryl Peltier, Danielle Desautels, David E Dawe, Versha Banerji
- Abstract
Loading... -
+
P3.12-02 - Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course
12:00 - 13:30 | Presenter: Anna F. Farago | Author(s): Kumiko Isse, Benjamin J. Drapkin, Vashine Kamesan, Marina Kem, Laura Saunders, Syed Quadri, Mari Mino-Kenudson
- Abstract
Loading... -
+
P3.12-03 - Targeting DLL3 with AMG 757, a BiTE® Antibody Construct, and AMG 119, a CAR-T, for the Treatment of SCLC
12:00 - 13:30 | Presenter: Michael Giffin | Author(s): Keegan Cooke, Edward Lobenhofer, Matthias Friedrich, Tobias Raum, Angela Coxon
- Abstract
Loading... -
+
P3.12-04 - Linc00173 Modulates Chemoresistance of Small Cell Lung Cancer by Binding hnRNPA2B1 and hnRNPI to Regulate CHK2 Level
12:00 - 13:30 | Presenter: Linlang Guo | Author(s): Fanrui Zeng, Qiongyao Wang, Shumei Liang
- Abstract
Loading... -
+
P3.12-05 - The Pattern of PD-L1 Expression in Thoracic Neuroendocrine Tumors
12:00 - 13:30 | Presenter: Nagla Abdel Karim | Author(s): Joshua Pathrose, Ihab El Desouki
- Abstract
Loading... -
+
P3.12-06 - SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
12:00 - 13:30 | Presenter: Taofeek Owonikoko | Author(s): Suzanne Dahlberg, Gabriel L Sica, John Poirier, Lauren Byers, Charles M. Rudin, Ignacio I. Wistuba, Suresh S. Ramalingam
- Abstract
Loading... -
+
P3.12-07 - MicroRNA Deregulation in a Typical Carcinoid Tumor: Potential Role of Immune Response and Invasion in Tumorigenesis.
12:00 - 13:30 | Presenter: Ana Laura Seneda | Author(s): Rainer Marco Lopez Lapa, Tainara Francini Felix, Cristiano Claudino Oliveira, Érica Nishida Hasimoto, Daniele Cristina Cataneo, Antonio José Maria Cataneo, Julio De Faveri, Sandra Aparecida Drigo, Patricia Pintor Dos Reis
- Abstract
Loading... -
+
P3.12-08 - The Role of Contactin 1 on Acquired Resistance to Pegylated Arginase in Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Sheng Yan | Author(s): Shi Xu, Sze Kwan Lam, Paul Ning-Man Cheng, James Chung-man Ho
- Abstract
Loading... -
+
P3.12-09 - Smad4 Mutation Confers Acquired Neuroendocrine Phenotype in Transformation of Lung Adenocarcinoma to Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Jie Zhang | Author(s): Xi Ding, Liping Zhang, Bo Su
- Abstract
Loading... -
+
P3.12-10 - Immunogenomic Characteristics of SCLC and LCNEC Redefined Molecular Subgroups
12:00 - 13:30 | Presenter: Xue-Tao Li | Author(s): Jian Su, Dan-Xia Lu, Jin -Ji Yang, Wen-Zhao Zhong, Yi-Long Wu, Xu-Chao Zhang, Jun Hou
- Abstract
Loading... -
+
P3.12-11 - Association of the Lung Immune Prognostic Index (LIPI) with Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients
12:00 - 13:30 | Presenter: Laura Mezquita | Author(s): Santiago Ponce Aix, Edouard Auclin, Alejandro Navarro, David Planchard, Ivana Sullivan, Gerard Zalcman, Julien Mazieres, Lizza Hendriks, Caroline Caramella, Margarita Majem, Pernelle Lavaud, Frank Aboubakar Nana, Enriqueta Felip, Luis Paz-Ares, Benjamin Besse
- Abstract
Loading... -
+
P3.12-12 - Genomic Profiling of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC) Reveals Distinct Mutational Landscape
12:00 - 13:30 | Presenter: Lin Wu | Author(s): Gen Lin, Xiaohua Hu, Likun Chen, Yingcheng Lin, Sheng Zhang, Zhang-Han Han, Jun-Yi Ye, Xinru Mao, Wenying Peng, Meilin Jiang
- Abstract
Loading... -
+
P3.12-13 - Expression of the Immune Checkpoint Axis-PVR/TIGIT in Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hui Yu | Author(s): Camilla Emma-Marie Koczara, Zoltan Lohinai, Andrzej Badzio, Piotr Czapiewski, Balázs Döme, Judit Moldvay, János Fillinger, Dexiang Gao, Kim Ellison, Shengxiang Ren, Charles Caldwell Jr, Christopher J. Rivard, Fred R. Hirsch
- Abstract
Loading... -
+
P3.12-14 - Genomic Profiling of Chinese Small Cell Lung Cancer and the Implications for Therapy
12:00 - 13:30 | Presenter: Hong Zhong | Author(s): Yu Wang, Jing Hu, Jian Guo, Yanhong Shang, Min Zheng, Jin Zhao, Yong Li, Jianjiang Xie, Honglin Guo, Jinwei Hu, Aodi Wang, Weifeng Wang, Weiwei Shi, Kai Wang, Ming Yao
- Abstract
Loading... -
+
P3.12-15 - 68 Ga DOTA PET/CT in Staging of Broncho-Pulmonary
Carcinoid Tumors. Is there a Real Benefit?12:00 - 13:30 | Presenter: George Karimundackal | Author(s): Vijayraj S Patil
- Abstract
Loading... -
+
P3.12-16 - Prognostic Impact of M Descriptors of the 8th Edition of TNM Classification for Extensive Disease-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Masayuki Shirasawa | Author(s): Tomoya Fukui, Seiichiro Kusuhara, Yasuhiro Hiyoshi, Mikiko Ishihara, Masashi Kasajima, Noriko Nishinarita, Shinya Harada, Satoshi Igawa, Masanori Yokoba, Hisashi Mitufuji, Masaru Kubota, Masato Katagiri, Jiichiro Sasaki, Katsuhiko Naoki
- Abstract
Loading... -
+
P3.12-17 - A Retrospective Study Examining the Role of PET-CT in the 8th TNM Staging System of SCLC
12:00 - 13:30 | Presenter: Salomon Tendler | Author(s): Vitali Grozman, Rolf Lewensohn, Georgios Tsakonas, Kristina Viktorsson, Luigi De Petris
- Abstract
Loading...